BHLHE40 contributes to allergic asthma progression in mice through NRTN downregulation in macrophages.
- Published in:
- Communications Biology, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s42003-025-08288-1
- By:
- Publication type:
- Article
Works by Shan, Lishen
Results: 10
1
2
Epigallocatechin gallate improves airway inflammation through TGF‑β1 signaling pathway in asthmatic mice.
- Published in:
- Molecular Medicine Reports, 2018, v. 18, n. 2, p. 2088, doi. 10.3892/mmr.2018.9183
- By:
- Publication type:
- Article
3
Expression of vitamin D receptor in bronchial asthma and its bioinformatics prediction.
- Published in:
- Molecular Medicine Reports, 2018, v. 18, n. 2, p. 2052, doi. 10.3892/mmr.2018.9157
- By:
- Publication type:
- Article
4
Human bone marrow-mesenchymal stem cell-derived exosomal microRNA-188 reduces bronchial smooth muscle cell proliferation in asthma through suppressing the JARID2/Wnt/β-catenin axis.
- Published in:
- Cell Cycle, 2022, v. 21, n. 4, p. 352, doi. 10.1080/15384101.2021.2020432
- By:
- Publication type:
- Article
5
FOXK2 facilitates the airway remodeling during chronic asthma by promoting glycolysis in a SIRT2‐dependent manner.
- Published in:
- FASEB Journal, 2024, v. 38, n. 13, p. 1, doi. 10.1096/fj.202302284R
- By:
- Publication type:
- Article
6
Efficacy and safety of omalizumab combined with allergen immunotherapy in children with moderate to severe allergic asthma.
- Published in:
- International Forum of Allergy & Rhinology, 2025, v. 15, n. 2, p. 208, doi. 10.1002/alr.23470
- By:
- Publication type:
- Article
7
Role of SYVN1 in the control of airway remodeling in asthma protection by promoting SIRT2 ubiquitination and degradation.
- Published in:
- Biological Research, 2023, v. 56, n. 1, p. 1, doi. 10.1186/s40659-023-00478-7
- By:
- Publication type:
- Article
8
Effects of Single-Nucleotide Polymorphisms in the TLR7 and TLR9 Genes of Asthmatic Children.
- Published in:
- Annals of Clinical & Laboratory Science, 2018, v. 48, n. 5, p. 601
- By:
- Publication type:
- Article
9
Systemic reactions to house dust mite subcutaneous immunotherapy in patients with allergic rhinitis and/or asthma: A real‐life, multi‐center study.
- Published in:
- Allergy, 2025, v. 80, n. 5, p. 1506, doi. 10.1111/all.16254
- By:
- Publication type:
- Article
10
Safety of subcutaneous immunotherapy with Novo-Helisen-Depot in the children: a retrospective analysis from a single center in Northern China.
- Published in:
- Frontiers in Pediatrics, 2024, p. 01, doi. 10.3389/fped.2024.1370224
- By:
- Publication type:
- Article